Chondrosarcoma
📧 Sign up to get email alerts when something new happens for Chondrosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: AG-120 in People With IDH1 Mutant Chondrosarcoma [Phase 2]
This update describes a Phase 2 study of AG-120 (ivosidenib) in patients with IDH1-mutant chondrosarcoma, with the trial currently active bu…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations [Phase 1]
Phase 1 study of LY3410738 in patients with IDH1/IDH2-mutant advanced solid tumors, including cholangiocarcinoma, chondrosarcoma, and glioma…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
ClinicalTrials.gov entry indicates recruitment for a study assessing healing and functional outcomes after reconstruction surgery for bone s…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating IACS-6274 with or without Bevacizumab and Paclitaxel in adults with advanced solid tumors; the study is cu…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors [Phase 2]
Phase 2 clinical trial evaluating the IDH2 inhibitor enasidenib (Idhifa) in IDH2-mutated malignant sinonasal and skull base tumors is curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Clinical Applicability of Liquid Biopsy in Chondrosarcoma
Clinical trial update evaluating the applicability of liquid biopsy in chondrosarcoma. The study (NCT07492823) is sponsored by the Medical U…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
A Mayo Clinic-sponsored trial is evaluating carbon ion therapy, surgery, and proton therapy for pelvic sarcomas involving bone. Recruitment …
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Proton Beam Therapy for Chondrosarcoma [Phase 2]
Phase 2 clinical trial update on proton beam therapy for chondrosarcoma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Expanded access (compassionate use) for the DNG64-CAR-V cell therapy in patients with advanced pancreatic cancer, various sarcoma subtypes, …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation [Phase 1]
Phase 1 study of AG-120 (ivosidenib) for IDH1-mutant advanced solid tumors, including glioma, has completed enrollment and data collection.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas [NA]
Investigates regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas and related subtypes. The trial is…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen [Phase 3]
Phase 3 trial evaluating ivosidenib in patients with conventional chondrosarcoma carrying an IDH1 mutation; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning [NA]
A clinical study sponsored by Ricoh USA, Inc. is evaluating the use of 3D-printed models to assist pre-operative planning for various sarcom…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
This clinical trial update notes a study evaluating adherence to a personalized home exercise program for bone tumor patients undergoing low…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base [NA]
A clinical trial is recruiting to evaluate hypofractionated proton therapy for skull base chordomas and chondrosarcomas.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Study of INBRX-109 in Conventional Chondrosarcoma [Phase 2]
A Phase 2 clinical trial evaluating INBRX-109 for conventional chondrosarcoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Diagnostic and Therapeutic Targets in Cartilaginous Tumours
A clinical trial is investigating diagnostic and therapeutic targets in cartilaginous tumours, with recruitment ongoing in Brno, Czech Repub…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET-imaging of Two Vartumabs in Patients With Solid Tumors [EARLY_Phase 1]
This early-phase PET-imaging trial evaluates two vartumabs in patients with solid tumors and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Proton Radiation for Chordomas and Chondrosarcomas [NA]
This clinical trial update notes that a proton radiation therapy study for chordoma and chondrosarcoma has completed and results have been p…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial [Phase 1]
This clinical trial update reports a Phase 1b study evaluating anti-osteoclast therapy as a neoadjuvant treatment for chondrosarcoma. The tr…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas [Phase 2]
Phase II clinical trial evaluating regorafenib for metastatic bone sarcomas is active but not recruiting, including Ewing sarcoma, chondrosa…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE
Describes a descriptive cohort of French patients treated with carbon ion therapy for various cancers, reported outside a PHRC-ETOILE progra…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration [Phase 2]
A Phase 2 clinical trial evaluating abemaciclib for bone and soft tissue sarcomas with CDK pathway alterations is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Long-Term Longitudinal QoL in Patients Undergoing EEA
ClinicalTrials.gov registry entry from Ohio State University indicates ongoing recruitment for a long-term quality-of-life study in patients…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers [Phase 1]
Aplitabart (IGM-8444) Phase 1a/1b study in solid tumors and various hematologic cancers was terminated.